microRNA 4289 (MIR4289)

microRNA 4289 (MIR4289) is a predicted or catalogued human microRNA, part of the large family of small non-coding RNAs (typically 21–23 nucleotides) that function in post-transcriptional regulation of gene expression by binding to target mRNAs to induce their degradation or inhibit their translation[1][5]. While microRNAs play essential roles in controlling gene expression in a wide variety of physiological and pathological processes, including development, cell cycle control, apoptosis, immune response, and cancer[2][4][7], there is no research specifically characterizing the biological function or clinical relevance of MIR4289. Most microRNAs are not “receptors” or “enzymes” but are gene-regulatory molecules, and only a subset have documented associations with disease pathways or clinical interventions.\n\nNote: The entry for MIR4289 is likely derived from genomic cataloguing efforts rather than experimental discovery; its sequence may exist in miRbase or similar genomic databases as predicted or computationally annotated. No significant research, druggability, or disease link has been reported to date. For structured use, MIR4289 should be flagged as “lacking established function” or “characterization incomplete.”

Other names

hsa-mir-4289MIR4289miR-4289microRNA 4289

Not applicable; no drugs reported to target MIR4289 specifically